Abiraterone acetate

abiraterone acetate  (A-bih-RA-teh-rone A-seh-tayt) is a drug used with prednisone to treat prostate cancer that has spread to other parts of the body.

Use in Cancer

Abiraterone acetate is approved to be used with prednisone to treat:

• Prostate cancer that has metastasized (spread to other parts of the body). It is used:
  • In patients whose disease is castration resistant (has not responded to treatments that lower testosterone levels). This use is approved for the Zytiga brand name of abiraterone acetate.
  • With methylprednisolone in patients whose disease is castration resistant. This use is approved for the Yonsa brand name of abiraterone acetate.
  • In patients whose disease is high-risk and castration sensitive (has responded to treatments that lower testosterone levels). This use is approved for the Zytiga brand name of abiraterone acetate.
  • It is also being studied in the treatment of other types of cancer.

How does it work?

Abiraterone acetate lowers the amount of androgens (male hormones), such as testosterone, made by the body. This may stop the growth of cancer cells that need androgens to grow.

Type of drug

Abiraterone acetate is a type of antiandrogen.

Other names

Also called Zytiga.

Latest research - Abiraterone acetate

• Most recent articles
• Most cited
• Ongoing trials